| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 6393 | 2018 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 4425 | 2018 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … GBD 2015 Risk Factors Collaborators Lancet (London, England) 388 (10053), 1659, 2016 | 2873 | 2016 |
| Nanoporous metal organic frameworks as hybrid polymer–metal composites for drug delivery and biomedical applications S Beg, M Rahman, A Jain, S Saini, P Midoux, C Pichon, FJ Ahmad, ... Drug Discovery Today 22 (4), 625-637, 2017 | 257 | 2017 |
| Metallic nanoparticles: technology overview & drug delivery applications in oncology MZ Ahmad, S Akhter, GK Jain, M Rahman, SA Pathan, FJ Ahmad, ... Expert opinion on drug delivery 7 (8), 927-942, 2010 | 244 | 2010 |
| Nanotechnology-based inhalation treatments for lung cancer: state of the art J Ahmad, S Akhter, M Rizwanullah, S Amin, M Rahman, MZ Ahmad, ... Nanotechnology, science and applications, 55-66, 2015 | 188 | 2015 |
| 3D printing for drug delivery and biomedical applications S Beg, WH Almalki, A Malik, M Farhan, M Aatif, Z Rahman, NK Alruwaili, ... Drug Discovery Today 25 (9), 1668-1681, 2020 | 173 | 2020 |
| Sedative, antiepileptic and antipsychotic effects of Viscum album L.(Loranthaceae) in mice and rats G Gupta, I Kazmi, M Afzal, M Rahman, S Saleem, MS Ashraf, MJ Khusroo, ... Journal of ethnopharmacology 141 (3), 810-816, 2012 | 166 | 2012 |
| Classical to current approach for treatment of psoriasis: a review M Rahman, K Alam, M Zaki Ahmad, G Gupta, M Afzal, S Akhter, I Kazmi, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2012 | 148 | 2012 |
| Advancement in multifunctional nanoparticles for the effective treatment of cancer M Rahman, MZ Ahmad, I Kazmi, S Akhter, M Afzal, G Gupta, ... Expert opinion on drug delivery 9 (4), 367-381, 2012 | 123 | 2012 |
| Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum M Afzal, G Gupta, I Kazmi, M Rahman, O Afzal, J Alam, KR Hakeem, ... Fitoterapia 83 (5), 853-858, 2012 | 122 | 2012 |
| Application of design of experiments (DoE) in pharmaceutical product and process optimization S Beg, S Swain, M Rahman, MS Hasnain, SS Imam Pharmaceutical quality by design, 43-64, 2019 | 110 | 2019 |
| Introduction to quality by design (QbD): fundamentals, principles, and applications S Beg, MS Hasnain, M Rahman, S Swain Pharmaceutical quality by design, 1-17, 2019 | 109 | 2019 |
| Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern S Akhter, M Zaki Ahmad, A Singh, I Ahmad, M Rahman, M Anwar, ... Current pharmaceutical design 17 (18), 1834-1850, 2011 | 107 | 2011 |
| Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin P Pandey, M Rahman, PC Bhatt, S Beg, B Paul, A Hafeez, FA Al-Abbasi, ... Nanomedicine 13 (8), 849-870, 2018 | 103 | 2018 |
| Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy M Rahman, S Akhter, J Ahmad, MZ Ahmad, S Beg, FJ Ahmad Expert opinion on drug delivery 12 (4), 635-652, 2015 | 94 | 2015 |
| Anti-diabetic potential of ursolic acid stearoyl glucoside: A new triterpenic gycosidic ester from Lantana camara I Kazmi, M Rahman, M Afzal, G Gupta, S Saleem, O Afzal, MA Shaharyar, ... Fitoterapia 83 (1), 142-146, 2012 | 91 | 2012 |
| Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products S Beg, M Rahman, K Kohli Drug discovery today 24 (3), 717-725, 2019 | 90 | 2019 |
| Functionalized mesoporous silica nanoparticles in anticancer therapeutics A Barkat, S Beg, SK Panda, KS Alharbi, M Rahman, FJ Ahmed Seminars in Cancer Biology 69, 365-375, 2021 | 83 | 2021 |
| Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art M Rahman, V Kumar, S Beg, G Sharma, OP Katare, F Anwar Artificial cells, nanomedicine, and biotechnology 44 (7), 1597-1608, 2016 | 76 | 2016 |
Amita VermaSam Higginbottom University of Agriculture, Technology and Sciences, AllahabadE-mail confirmado em shiats.edu.in
